ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,743.07
-0.30%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.645
-0.02%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Entasis Therapeutics Holdings Inc (ETTX)

  7. Entasis Therapeutics Holdings Inc (ETTX) ニュース

ETTX

Entasis Therapeutics (ETTX)

Entasis Therapeutics Holdings Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ETTX
日付受信時刻ニュースソース見出しコード企業名
2022/10/1221 : 30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/2206 : 28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206 : 13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0906 : 05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0906 : 02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0905 : 55Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0905 : 49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0821 : 35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0119 : 04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721 : 11Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721 : 09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721 : 04Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1720 : 58Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ETTX

最近閲覧した銘柄

BIT
UB7HUM
Unicredit Bank
NASDAQ
XT
iShares Exponential Tech...
EU
V455S
V455S
EU
R684S
R684S
BIT
S31316
Societe Generale Effekten
ASE
KYRI
Kiriacoulis Shipping
BIT
P1L2P2
BNP Paribas Issuance
BIT
S31326
Societe Generale Effekten
AMEX
OUNZ
VanEck Merk Gold
BIT
F34551
Vontobel Financial Produ...
USOTC
AGTAF
Agriterra (PK)
EU
CDCES
Caisse Depots et Consign...
ASX
MKL
Mighty Kingdom
USOTC
YBCN
Yong Bai Chao New Retail (PK)
BIT
P1TPO0
BNP Paribas Issuance
NYSE
USB.P.S
US Bancorp (DE)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有